Clinical Trials Directory

Trials / Completed

CompletedNCT07018973

The Effect of Artificial Intelligence Supported Morphological Analysis on Problem Solving and Creative Thinking Disposition

The Role of Generative Artificial Intelligence Supported Morphological Analysis on Problem Solving Skills and Creative Thinking Disposition of Nursing Students: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
113 (actual)
Sponsor
Gazi University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

It will be conducted as a two-group, pretest-posttest, randomized controlled study to determine the effect of generative artificial intelligence-supported morphological analysis on nursing students' problem solving skills and creative thinking tendencies. This study will be conducted with third year students who enrolled in Gazi University Faculty of Health Sciences, Department of Nursing, HEM 312 Critical Thinking in Nursing course for the first time in the spring semester of the 2024-2025 academic year and agreed to participate in the study. Data will be collected using the "Inclusion Form", "Descriptive Characteristics Form", "Marmara Creative Thinking Dispositions Scale", "Problem Solving Skills Scale for Adults" and "Morphological Analysis and Generative Artificial Intelligence Application Opinion Form". Students who meet the inclusion criteria will be randomized into intervention and control groups according to the midterm exam results of the course. At the end of the intervention, post-tests (Marmara Creative Thinking Dispositions Scale and Problem Solving Skills Scale for Adults) will be administered. The control group will be allowed to use the generative artificial intelligence after completing the post-tests. When the application is completed, students will be given an opinion form and their opinions will be taken. The data of the intervention and control groups will be analyzed with SPSS in computer environment.

Detailed description

Students assigned to groups will start morphological analysis for the problems to be given within the scope of patient safety objectives in groups of 5-6 people. One group in the experimental and one group in the control group will be distributed in such a way that the same problem will coincide. Information about the morphological analysis method will be given before the application. The matrix papers made in morphological analysis will be distributed to the groups and the students will be enabled to create their matrices, select their combinations and produce solutions. Researchers will provide coordination in groups. One of the researchers took a course on creative thinking techniques. After the application, the study will be completed with the presentation of matrix, combination and solution proposals of the experimental and control groups. Thus, the implementation will be completed in one day and the study will be finalized by taking post-tests and opinion forms.

Conditions

Interventions

TypeNameDescription
OTHERGAISMAAfter the pre-test and randomization, the experimental group will first start the morphological analysis application. After completing a certain period of time, copies of the matrix and suggestion studies will be taken and they will be allowed to use the generative artificial intelligence application. At the end of the application, a post-test will be applied. In addition, an opinion form will be given and their opinions about the morphological analysis method, the use of generative artificial intelligence and the use of artificial intelligence with the morphological analysis method and how it affects them will be taken.
OTHERControlIn the control group, morphological analysis will be applied. Post-tests will be applied at the end of the application. Finally, their opinions about the morphological analysis method and how it affects them will be taken by giving an opinion form.

Timeline

Start date
2025-06-12
Primary completion
2025-06-13
Completion
2025-06-13
First posted
2025-06-13
Last updated
2025-06-17

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07018973. Inclusion in this directory is not an endorsement.